Cargando…

P843: ABERRANT M5C MODIFICATION OF LNCRNA MALAT1 IS ASSOCIATED WITH BONE LESIONS FORMATION IN MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales:	Cui, Xing, Yu, Manya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431139/ http://dx.doi.org/10.1097/01.HS9.0000970276.89109.78

Ejemplares similares

P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS
por: Steer, A., et al.
Publicado: (2022)

843. Targeted HIV Testing for Patients Hospitalized for COVID-19
por: Virata, Michael D, et al.
Publicado: (2021)

Aberrant lncRNA Expression in Multiple Myeloma
por: Meng, Hui, et al.
Publicado: (2018)

843. Increased Carbapenemase Testing Following Implementation of VA Guidelines for Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Fitzpatrick, Margaret A, et al.
Publicado: (2020)

Nucleation of Helium in Liquid Lithium at 843 K and High Pressures
por: Martí, Jordi, et al.
Publicado: (2022)

Indexation of extravascular lung water in unselected adult patients with and without mechanical ventilation: a prospective study in 50 patients with 843 transpulmonary thermodilutions
por: Huber, W, et al.
Publicado: (2012)

EPC‐derived exosomes promote osteoclastogenesis through LncRNA‐MALAT1
por: Cui, Yigong, et al.
Publicado: (2019)

P831: NOVEL IMMUNOSUPPRESSIVE MYELOID POPULATIONS IN THE BONE MARROW (BM) AND OSTEOLYTIC LESIONS (OL) OF MULTIPLE MYELOMA (MM) PATIENTS
por: Hillengass, Jens, et al.
Publicado: (2023)

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
por: Nakaue, Emiko, et al.
Publicado: (2023)

P882: IDENTIFICATION OF M7G RNA METHYLATION REGULATORS AND M7G-RELATED GENES IN MULTIPLE MYELOMA
por: Yu, M., et al.
Publicado: (2022)

Le film de l'histoire médiévale en France, 843-1328 /
por: Latouche, Robert, 1881-
Publicado: (1959)

Down-regulation of lncRNA MALAT1 alleviates vascular lesion and vascular remodeling of rats with hypertension
por: Xue, Yu-Zeng, et al.
Publicado: (2019)

Epigenetic Aberrations in Multiple Myeloma
por: Caprio, Cinzia, et al.
Publicado: (2020)

Regulatory Networks of LncRNA MALAT-1 in Cancer
por: Fu, Shijian, et al.
Publicado: (2020)

P939: THE RELATIONSHIP OF BONE MARROW FIBROSIS WITH EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
por: Konyaoglu, Hilal, et al.
Publicado: (2023)

Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma
por: Sun, Zhen, et al.
Publicado: (2020)

Aberrant bone metabolism in critical illness
por: Vanhees, I, et al.
Publicado: (2012)

Complete Genomic Structure of the Bloom-forming Toxic Cyanobacterium Microcystis aeruginosa NIES-843
por: Kaneko, Takakazu, et al.
Publicado: (2007)

Construction, expression, and characterization of AG1(1–843) and AG1(1–1581)
por: Yan, Xie, et al.
Publicado: (2018)

LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression
por: Gu, Yueli, et al.
Publicado: (2017)

Management of Myeloma Bone Lesions
por: Du, Jeng-Shiun, et al.
Publicado: (2021)

Osteogenic Differentiation of Renal Interstitial Fibroblasts Promoted by lncRNA MALAT1 May Partially Contribute to Randall’s Plaque Formation
por: Zhu, Zewu, et al.
Publicado: (2021)

P842: RAS-ERK PATHWAY GENES MUTATIONS IN THE LESIONS FROM VARIOUS TUMOR LOCI IN MULTIPLE MYELOMA
por: Soloveva, Maiia, et al.
Publicado: (2023)

P870: DEFINING A NOVEL FUNCTION FOR THE POST-TRANSLATIONAL MODIFICATION UFMYLATION IN THE ADAPTIVE RESPONSE TO ARGININE DEPRIVATION IN MULTIPLE MYELOMA
por: Romano, A., et al.
Publicado: (2022)

Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
por: Amodio, Nicola, et al.
Publicado: (2018)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Predisposition to Lung Adenocarcinoma in a Family Harboring the Germline EGFR V843I Mutation
por: Ohtsuka, Kouki, et al.
Publicado: (2019)

METTL3-Mediated m(6)A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling
por: Mao, Yuanshen, et al.
Publicado: (2022)

P824: LNCRNA SNHG15 BINDS DDX5 TO INDUCE R-LOOP-BASED DNA DAMAGE REPAIR TO PROMOTE BTZ RESISTANCE IN MULTIPLE MYELOMA
por: Yao, Lan, et al.
Publicado: (2023)

A novel circRNA-miRNA-mRNA network revealed exosomal circ-ATP10A as a biomarker for multiple myeloma angiogenesis
por: Yu, Manya, et al.
Publicado: (2021)

Is 99m Tc-methylene diphosphonate bone scintigraphy a sensitive method for detecting bone lesions in multiple myeloma?
por: Vakili Sadeghi, Mohsen, et al.
Publicado: (2018)

The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis
por: Elamir, Azza M., et al.
Publicado: (2021)

Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance
por: Hou, Junhui, et al.
Publicado: (2023)

LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization
por: Zhang, Xiaoli, et al.
Publicado: (2023)

Molecular genetic aberrations in the pathogenesis of multiple myeloma
por: Bong, Ivyna Pau Ni, et al.
Publicado: (2023)

P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
por: Popat, R, et al.
Publicado: (2022)

An Integrated Transcriptomics and Proteomics Analysis Implicates lncRNA MALAT1 in the Regulation of Lipid Metabolism
por: Wang, Hao, et al.
Publicado: (2021)

P1338: VASCULARIZED BONE MARROW-ON-CHIP TO STUDY VASCULAR ABERRATION IN HEMATOPOIETIC DISEASES
por: Bessy, Thomas, et al.
Publicado: (2023)

Erratum to “Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy” [Sci Pharm. 2013; 81: 843–854]
por: Gulati, Neha, et al.
Publicado: (2013)

Genetic and Phenotypic Characterization of the Etiological Agent of Canine Orchiepididymitis Smooth Brucella sp. BCCN84.3
por: Guzmán-Verri, Caterina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f57peud1kbjvofdiejp8a29tso